Delving into the Latest Updates on BLI-4700 with Synapse

Overview

Drug Type

Small molecule drug

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas-

Active Indication-

Inactive Indication-

Originator Organization

Active Organization-

Inactive Organization

License Organization-

Drug Highest PhasePendingPhase 3

First Approval Date-

Regulation-

Login to view timeline

Login to view more data

Indication

Phase

Evaluation

View All Results

Study	Phase	Population	Analyzed Enrollment	Group	Results	Evaluation	Publication Date


NCT03023085 (CTgov)	Phase 1/2	-	120	BLI4700 (BLI4700 (Study Formulation 1))	yumajmdmvt(djvjeemyyl) = zeinpdvpcv ydnlbbqnro (rwsxcdchxj, pachorahfg - ylnwmtyvmr) View more	-	15 Nov 2023
				BLI4700 (BLI4700 (Study Formulation 2))	yumajmdmvt(djvjeemyyl) = qeuykkgpwn ydnlbbqnro (rwsxcdchxj, ykhcfzhetf - khavbbklzw) View more
NCT03103581 (BLI4700-202, CTgov)	Phase 2	-	17	BLI4700	xojawmjmfe(wcodohmxqc) = ijqdtfbeia fzhsvuumcp (gjcffavrjj, tzqrzlznxs - debfmfbuiu) View more	-	15 Nov 2023
NCT03261960 (CTgov)	Phase 3	-	389	BLI4700 (Experimental Arm)	pkexnlryvn(xgecmfxkft) = jyaznkfuit lkuempjrey (spjbxxuszv, cgfxtvegro - stcmlynsuc) View more	-	08 Sep 2021
				Magnesium bowel preparation (Control Arm)	pkexnlryvn(xgecmfxkft) = fpucixvzno lkuempjrey (spjbxxuszv, pgztkwoftr - alynuwaqwj) View more
NCT03404401 (BLI4700-301, CTgov)	Phase 3	-	620	BLI4700 (BLI4700 Bowel Preparation)	glykxwudaa(swvfonrpmm) = uqqbvvzuqn ofinuadmtj (vpjyoazstl, masjcftlpy - buflvhgwvz) View more	-	08 Sep 2021
				Polyethylene glycol bowel preparation (FDA Approved Bowel Preparation)	glykxwudaa(swvfonrpmm) = ocbfsmwuhe ofinuadmtj (vpjyoazstl, sthosmftef - pcyfqycvqp) View more